Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02394548 · ClinicalTrials.gov registry record · NA
Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT02394548: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02394548 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02394548, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
This research study is examining the benefit of a novel radiation planning approach on the likelihood of developing severe esophagitis (irritation and inflammation of the esophagus) during the course of radiation therapy with concurrent chemotherapy which is associated with very painful and difficult swallowing.
Interventions
- RADIATION Contralateral Esophageal Sparing Technique (CEST)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2015-06 |
| Est. Completion | 2021-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02394548
The ClinicalTrials.gov registry entry for NCT02394548 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Contralateral Esophageal Sparing Technique (CEST) is the first listed.
NCT02394548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02394548 about?
NCT02394548 is a clinical study titled "Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer". This research study is examining the benefit of a novel radiation planning approach on the likelihood of developing severe esophagitis (irritation and inflammation of the esophagus) during the course of radiation therapy with concurrent chemotherapy which is associated with very painful and difficul...
What is the current status of trial NCT02394548?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2015-06. Estimated completion is 2021-03.
What interventions are being tested in trial NCT02394548?
The interventions under investigation include: Contralateral Esophageal Sparing Technique (CEST) (RADIATION).
Who is sponsoring clinical trial NCT02394548?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.